News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Caris Life Sciences Release: Novel Findings for Molecular Profiling of Head and Neck Squamous Cell Carcinoma (HNSCC) Presented at the 2012 Multidisciplinary Head & Neck Cancer Symposium


2/2/2012 9:58:08 AM

IRVING, Texas, Feb. 2, 2012 (GLOBE NEWSWIRE) -- Caris Life Sciences™, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality molecular profiling and blood-based diagnostic services, recently presented a clinical poster at the 2012 Multidisciplinary Head & Neck Cancer Symposium. The poster entitled, "Biomarker expression in Head and Neck Squamous Cell Carcinoma (HNSCC) – Implications for Therapy," demonstrated the clinical value of molecular profiling in helping physicians develop individualized cancer treatment strategies for this aggressive tumor type with an often unpredictable prognosis. This study retrospectively reviewed data aggregated from tumors molecularly profiled with Caris Target Now.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES